New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy
- PMID: 27975071
- PMCID: PMC5128713
- DOI: 10.1155/2016/9720912
New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy
Erratum in
-
Corrigendum to "New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy".J Immunol Res. 2018 Jul 29;2018:6728474. doi: 10.1155/2018/6728474. eCollection 2018. J Immunol Res. 2018. PMID: 30151395 Free PMC article.
Abstract
The majority of basic and clinical studies have shown a protumor function of tumor-associated macrophages (TAMs), which represent a large proportion of matrix cells. TAMs promote tumorigenesis, and their number is related to the malignancy degree and poor prognosis of many kinds of tumors. Macrophage plasticity makes it possible to change the tumor microenvironment and remodel antitumor immunity during cancer immunotherapy. Increasing numbers of studies have revealed the effects of TAMs on the tumor microenvironment, for example, via promotion of tumor growth and tumorigenesis and through an increase in the number of cancer stem cells or via facilitation of angiogenesis, lymphangiogenesis, and metastasis. Investigators also proposed tumor-immunological treatments targeting TAMs by inhibiting TAM recruitment and differentiation, by regulating TAM polarization, and by blocking factors and pathways associated with the protumor function of TAMs. This comprehensive review presents recent research on TAMs in relation to prediction of poor outcomes, remodeling of the tumor immune microenvironment, and immunological targeted therapies.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Tumor-associated macrophages: role in cancer development and therapeutic implications.Cell Oncol (Dordr). 2019 Oct;42(5):591-608. doi: 10.1007/s13402-019-00453-z. Epub 2019 May 29. Cell Oncol (Dordr). 2019. PMID: 31144271 Review.
-
Targeting tumor-associated macrophages: A potential treatment for solid tumors.J Cell Physiol. 2021 May;236(5):3445-3465. doi: 10.1002/jcp.30139. Epub 2020 Nov 16. J Cell Physiol. 2021. PMID: 33200401 Review.
-
The roles of tumor-associated macrophages in tumor angiogenesis and metastasis.Cell Immunol. 2020 Jul;353:104119. doi: 10.1016/j.cellimm.2020.104119. Epub 2020 May 4. Cell Immunol. 2020. PMID: 32446032 Review.
-
Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.Oncotarget. 2017 Jul 18;8(29):48436-48452. doi: 10.18632/oncotarget.17061. Oncotarget. 2017. PMID: 28467800 Free PMC article. Review.
-
Blockade of DC-SIGN+ Tumor-Associated Macrophages Reactivates Antitumor Immunity and Improves Immunotherapy in Muscle-Invasive Bladder Cancer.Cancer Res. 2020 Apr 15;80(8):1707-1719. doi: 10.1158/0008-5472.CAN-19-2254. Epub 2020 Feb 14. Cancer Res. 2020. PMID: 32060149
Cited by
-
Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma.J Immunol Res. 2018 Oct 16;2018:7819520. doi: 10.1155/2018/7819520. eCollection 2018. J Immunol Res. 2018. PMID: 30410942 Free PMC article. Review.
-
Metabolic Plasticity of Stem Cells and Macrophages in Cancer.Front Immunol. 2017 Aug 9;8:939. doi: 10.3389/fimmu.2017.00939. eCollection 2017. Front Immunol. 2017. PMID: 28848547 Free PMC article. Review.
-
Recent Advances in Macrophage-Mediated Drug Delivery Systems.Int J Nanomedicine. 2021 Apr 7;16:2703-2714. doi: 10.2147/IJN.S298159. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33854316 Free PMC article. Review.
-
The prognostic value of tumor-associated macrophages detected by immunostaining in diffuse large B cell lymphoma: A meta-analysis.Front Oncol. 2023 Jan 20;12:1094400. doi: 10.3389/fonc.2022.1094400. eCollection 2022. Front Oncol. 2023. PMID: 36741724 Free PMC article.
-
Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer: An Integrative View.Front Cardiovasc Med. 2022 Feb 14;9:777822. doi: 10.3389/fcvm.2022.777822. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35237673 Free PMC article. Review.
References
-
- Owonikoko T. K., Dahlberg S. E., Khan S. A., et al. A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E2511) Lung Cancer. 2015;89(1):66–70. doi: 10.1016/j.lungcan.2015.04.015. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases